Back to search

Article

Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infection

2022-04-06

Abstract excerpt

Tuberculosis remains one of the leading causes of death from a single infectious agent, surpassing both AIDS and malaria. In recent years, two bicyclic nitroimidazole drugs, delamanid and pretomanid have been approved to treat this airborne infection. This has spurred a renewed interest in developing new and improved nitroimidazole analogs. We have previously identified a new bicyclic heteroaromatic subclass, the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5edac48d-abe1-507c-bf50-c52417d4fe41
DOI
10.1101/2022.04.05.487095
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infectionDOI 10.1101/2022.04.05.487095
Select a neighboring publication to make it the new centre.